Understanding the function of epigenetic modification in the context of ARDS opens opportunities for the utilization of epigenetic modulators, such as PAD4 inhibitors, HDAC inhibitors, DNMT inhibitors, and PAR1 antagonists, for precision treatment. The gene discussed is F2R; the disease is acute respiratory distress syndrome.